This article is more than 5 years old. Information may no longer be current.

STAAR Surgical Toric ICL gets CE mark

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

MONROVIA, Calif. — The STAAR Toric ICL has received the CE mark from the European Union.

The Toric ICL is a posterior chamber phakic IOL designed both to reduce existing astigmatism and to provide correction of myopia or hyperopia in one procedure.

The lenses are “made-to-order for each patient,” said David Bailey, president and chief executive officer of STAAR. The company received approval from the U.S. Food and Drug Administration in Jan. 2002 to initiate clinical investigation of the lens in the United States.

Before receiving the CE mark, STAAR had delivered the Toric ICLs to physicians under the ‘named patient’ procedure, according to Mr. Bailey.